Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

Blog Posts by NCI Director Dr. Anthony Letai

In posts written for Cancer Currents Blog and NCI Bottom Line: A Blog about Grants and More, Dr. Anthony Letai shares his vision and priorities for NCI, reflects on advances and emerging opportunities in cancer research and care, and highlights how collaboration and scientific innovation can help accelerate progress for people with cancer.

  • A large group of workshop attendees poses for a photo in a large meeting room. A screen behind them reads, “It’s session break time! We will return shortly.”

    Could Functional Precision Medicine Be the New Precision Oncology?

    Posted August 6, 2026
    Functional precision medicine tests drugs directly on living tumor cells to help clinicians identify the most effective, personalized treatments for their patients. NCI Director Dr. Anthony Letai shares his personal journey with the technology and highlights next steps for advancing the field from a recent NCI workshop.

  • Health care provider in protective equipment uses a pipette to transfer red liquid into a laboratory tube inside a biosafety cabinet.

    Guidance on Applications for Studies with Animal Models 

    Posted August 4, 2026
    NCI Director Anthony Letai shares new guidance for grant applications involving animal models. Read his advice on selecting the most relevant research approaches and what applicants should address in future submissions.

  • Dr. Anthony Letai stands at a lectern on a stage and addresses attendees filling rows of seats in a large conference hall.

    Reflections on Progress and Partnership at ASCO 2026

    Posted June 16, 2026
    Following ASCO 2026, NCI Director Dr. Anthony Letai reflects on the pace of progress in cancer research, efforts to accelerate clinical trials, and NCI’s role in supporting the cancer research and care community. He highlights how decades of investment in science are driving progress for patients and creating new opportunities to improve outcomes.

  • Icon showing a white open book with lines of text and a checkmark symbol, set within a circular design on a teal gradient background.

    An Update on Grantmaking at NCI

    Posted May 29, 2026
    Dr. Letai discusses the current status of grants for fiscal year 2026 and what NCI is doing to fund the best science as quickly as possible.

  • About 70 professionally dressed people smiling at the camera and standing in a semicircle in front of the NCI exhibit booth.

    Your NCI: Top Priorities from AACR 2026

    Posted May 4, 2026
    NCI Director Dr. Anthony Letai shares his reflections on this year’s AACR Annual Meeting, including science that stood out and NCI’s leading priorities.

Email